Results 301 to 310 of about 146,942 (386)

Key Challenges for Commercializing Perovskite–Silicon Tandem Solar Cells

open access: yesCarbon Energy, EarlyView.
This review discusses the scientific and technological challenges in advancing perovskite–silicon tandem solar cells (PSTSCs) from lab‐scale to commercial viability, focusing on long‐term stability, scalability, and economic feasibility. Key issues include intrinsic and extrinsic degradation factors, installation conditions, environmental impacts, and ...
Bilal Mehmood   +16 more
wiley   +1 more source

Icon

open access: yesThe Iowa Review, 2000
openaire   +1 more source

Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction Performance

open access: yesChemistry – A European Journal, EarlyView.
This review covers the application of the bifunctional approach to photocatalysis as a means to attain (enhanced) enantioselectivity, and, more in general, as a strategy to enhance the catalytic performance through an effective use of short‐lived reaction intermediates.
Luigi Dolcini   +3 more
wiley   +1 more source

Correlative Electron Paramagnetic Resonance Imaging and Atomic Force Microscopy of Lithium Deposited on Copper

open access: yesChemPhysChem, Volume 26, Issue 6, March 15, 2025.
The correlation of a spectroscopic (EPRI) and microscopic (AFM) technique is demonstrated for a sample of Li deposited on Cu. Areas of different morphology were analysed. The techniques complement each other's length scales as well as the information obtained from the sample.
Beatrice Wolff   +5 more
wiley   +1 more source

Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Dupilumab, a fully human monoclonal antibody that blocks key drivers of type 2 inflammation, is approved across 8 diseases, including eosinophilic esophagitis. Subcutaneous dupilumab 300 mg weekly improved outcomes vs. placebo in adults (aged ≥ 18 years) and adolescents (aged ≥ 12 to < 18 years) during the phase III LIBERTY EoE TREET study (NCT03633617)
Jenny‐Hoa Nguyen   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy